Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Scientist

Bioengineering · India · 2025-02-03

Processing Time
313 days
Decision Date
2025-02-03
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the national health burden of cancer and genetic disorders through biotechnology innovation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 343 citations demonstrate his capability to lead these research efforts.

3 Balance of Interests Met

The benefit of advancing life-saving therapies outweighs the requirement for a labor certification.

Why This Petition Was Approved

The petition was approved based on 11 peer-reviewed journal articles, 2 abstracts, and 343 citations. The petitioner also completed 10 peer reviews and secured funding from prestigious institutions like the NIH and DOD. Two expert recommendation letters confirmed his influence on the development of novel cell therapies.

Request for Evidence (RFE)

Successfully Addressed

An RFE was issued during the 10-month processing period; the legal team provided diligent support to address USCIS's requests, leading to approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 10 days 2023-08-24
The petitioner proposes to investigate novel strategies for diagnosis, drug delivery, and immunotherapy to develop new treatments for cancer. His work focuses on developing the AESOP platform, a microfluidic cell deformation system designed to improve the safety and efficiency of intracellular gene editing delivery.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2025-02-18
The petitioner proposes to utilize single-cell multi-omic analysis and high-throughput microscopy to identify molecular and systems-level processes driving carcinogenesis and immune responses. This work aims to uncover mechanisms governing cellular decision-making to enable more precise and effective cancer treatments.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 313 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist